Organization
Dr. Falk Pharma
4 clinical trials
Clinical trial
Double-blind, Randomised, Placebo-controlled, Phase IIb Trial on the Efficacy and Safety of Norursodeoxycholic Acid Tablets in Patients With Non-alcoholic Steatohepatitis (NASH)Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Double-blind, Randomised, Placebo-controlled, Dose-finding Phase IIb Trial to Evaluate the Efficacy, Safety, and Tolerability of a 12-week-treatment With Naronapride in Adult Participants With at Least Moderate Idiopathic or Diabetic GastroparesisStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Open-label, Monocentric Phase IIa Pilot Study Evaluating the Efficacy and Tolerability of a 4-week Treatment With Mesalazine Oral Suspension in Patients With Active Eosinophilic EsophagitisStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Double-blind, Randomized, Placebo-controlled, Phase II Dose-finding Study Comparing Different Doses of ZED1227 Capsules With Placebo in the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) With Significant FibrosisStatus: Completed, Estimated PCD: 2023-06-07